Septerna Insider Trades
NASDAQ: SEPNHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 0 · $0
- Sales
- 27 · $76.05M
- Shares bought / sold
- 0 / 1.80M
- Net activity
- Net selling $76.1 million
Septerna insider activity
Over the last 12 months, Septerna insiders reported 47 transactions on SEC Form 4: 0 open-market purchases and 27 sales. Insiders bought $0 and sold $76.1 million worth of stock, for net insider selling of $76.1 million. The largest seller was RA CAPITAL MANAGEMENT, L.P. & RA Capital Healthcare Fund LP & RA Capital Nexus Fund III, L.P. & Kolchinsky Peter & Shah Rajeev M., with $63.5 million in reported sales.
The most recent filing shows Long Daniel D. (SVP, Drug Discovery) reporting a transaction in 3,333 shares at $2.76 on Sep 1, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put SEPN's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
SEPN insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Sep 1, 2026 | Long Daniel D.SVP, Drug Discovery | Sale | 3,333 | $126.08K | Form 4 |
| Sep 1, 2026 | Long Daniel D.SVP, Drug Discovery | Option exercise | 3,333 | $9.20K | Form 4 |
| Aug 12, 2026 | RA CAPITAL MANAGEMENT, L.P. & RA Capital Healthcare Fund LP & RA Capital Nexus Fund III, L.P. & Kolchinsky Peter & Shah Rajeev M.Director | Sale | 746,500 | $31.73M | Form 4 |
| Aug 12, 2026 | RA CAPITAL MANAGEMENT, L.P. & RA Capital Healthcare Fund LP & RA Capital Nexus Fund III, L.P. & Kolchinsky Peter & Shah Rajeev M.Director | Sale | 746,500 | $31.73M | Form 4 |
| Aug 12, 2026 | Third Rock Ventures V, L.P. & Third Rock Ventures GP V, LP & TRV GP V, LLC & Third Rock Ventures VI, L.P. & Third Rock Ventures GP VI, L.P. & TRV GP VI, LLC10% Owner | Sale | 141 | $7.20K | Form 4 |
| Aug 12, 2026 | Third Rock Ventures V, L.P. & Third Rock Ventures GP V, LP & TRV GP V, LLC & Third Rock Ventures VI, L.P. & Third Rock Ventures GP VI, L.P. & TRV GP VI, LLC10% Owner | Sale | 147,059 | $7.39M | Form 4 |
| Aug 11, 2026 | Bhatt ElizabethPresident and COO | Sale | 25,000 | $1.10M | Form 4 |
| Aug 11, 2026 | Bhatt ElizabethPresident and COO | Option exercise | 6,319 | $17.44K | Form 4 |
| Aug 11, 2026 | Bhatt ElizabethPresident and COO | Option exercise | 18,681 | $127.22K | Form 4 |
| Aug 3, 2026 | Long Daniel D.SVP, Drug Discovery | Sale | 2,334 | $80.94K | Form 4 |
| Aug 3, 2026 | Long Daniel D.SVP, Drug Discovery | Sale | 1,000 | $33.98K | Form 4 |
| Aug 3, 2026 | Long Daniel D.SVP, Drug Discovery | Option exercise | 1,518 | $4.19K | Form 4 |
| Aug 3, 2026 | Long Daniel D.SVP, Drug Discovery | Option exercise | 1,816 | $5.01K | Form 4 |
| Jul 15, 2026 | Bhatt ElizabethPresident and COO | Sale | 4,000 | $135.97K | Form 4 |
| Jul 15, 2026 | Bhatt ElizabethPresident and COO | Option exercise | 4,000 | $27.24K | Form 4 |
| Jul 1, 2026 | Long Daniel D.SVP, Drug Discovery | Sale | 1,233 | $42.93K | Form 4 |
| Jul 1, 2026 | Long Daniel D.SVP, Drug Discovery | Sale | 2,100 | $71.60K | Form 4 |
| Jul 1, 2026 | Long Daniel D.SVP, Drug Discovery | Option exercise | 3,333 | $9.20K | Form 4 |
| Jun 29, 2026 | Shaikhly SamiraChief People Officer | Sale | 2,178 | $76.62K | Form 4 |
| Jun 29, 2026 | Shaikhly SamiraChief People Officer | Option exercise | 2,178 | $14.83K | Form 4 |
| Jun 22, 2026 | Long Daniel D.SVP, Drug Discovery | Sale | 7,000 | $251.78K | Form 4 |
| Jun 22, 2026 | Long Daniel D.SVP, Drug Discovery | Sale | 8,000 | $280.80K | Form 4 |
| Jun 22, 2026 | Long Daniel D.SVP, Drug Discovery | Option exercise | 4,471 | $52.31K | Form 4 |
| Jun 22, 2026 | Long Daniel D.SVP, Drug Discovery | Option exercise | 10,529 | $29.06K | Form 4 |
| Jun 12, 2026 | Shaikhly SamiraChief People Officer | Sale | 6,250 | $219.22K | Form 4 |
| Jun 12, 2026 | Shaikhly SamiraChief People Officer | Option exercise | 6,250 | $73.13K | Form 4 |
| Jun 1, 2026 | Shaikhly SamiraChief People Officer | Sale | 2,889 | $85.70K | Form 4 |
| Jun 1, 2026 | Shaikhly SamiraChief People Officer | Sale | 1,346 | $38.76K | Form 4 |
| Jun 1, 2026 | Shaikhly SamiraChief People Officer | Sale | 1,700 | $47.23K | Form 4 |
| Jun 1, 2026 | Shaikhly SamiraChief People Officer | Option exercise | 637 | $1.76K | Form 4 |
| Jun 1, 2026 | Shaikhly SamiraChief People Officer | Option exercise | 943 | $2.60K | Form 4 |
| Jun 1, 2026 | Shaikhly SamiraChief People Officer | Option exercise | 4,355 | $6.75K | Form 4 |
| May 26, 2026 | Shaikhly SamiraChief People Officer | Sale | 11,798 | $354.66K | Form 4 |
| May 26, 2026 | Shaikhly SamiraChief People Officer | Option exercise | 11,798 | $80.34K | Form 4 |
| Apr 15, 2026 | Bhatt ElizabethPresident and COO | Sale | 326 | $8.43K | Form 4 |
| Apr 15, 2026 | Bhatt ElizabethPresident and COO | Sale | 1,101 | $27.79K | Form 4 |
| Apr 15, 2026 | Bhatt ElizabethPresident and COO | Sale | 2,573 | $61.12K | Form 4 |
| Apr 15, 2026 | Bhatt ElizabethPresident and COO | Option exercise | 4,000 | $27.24K | Form 4 |
| Mar 2, 2026 | Shaikhly SamiraChief People Officer | Sale | 66,363 | $1.87M | Form 4 |
| Mar 2, 2026 | Shaikhly SamiraChief People Officer | Sale | 4,090 | $112.50K | Form 4 |
| Mar 2, 2026 | Shaikhly SamiraChief People Officer | Option exercise | 5,101 | $14.08K | Form 4 |
| Mar 2, 2026 | Shaikhly SamiraChief People Officer | Option exercise | 11,638 | $32.12K | Form 4 |
| Mar 2, 2026 | Shaikhly SamiraChief People Officer | Option exercise | 53,714 | $83.26K | Form 4 |
| Feb 18, 2026 | Bhatt ElizabethPresident and COO | Sale | 1,800 | $53.25K | Form 4 |
| Feb 18, 2026 | Bhatt ElizabethPresident and COO | Sale | 2,200 | $62.61K | Form 4 |
| Feb 18, 2026 | Bhatt ElizabethPresident and COO | Option exercise | 4,000 | $27.24K | Form 4 |
| Nov 10, 2025 | Long Daniel D.SVP, Drug Discovery | Sale | 3,501 | $63.22K | Form 4 |
| Aug 18, 2025 | Klein UweSVP, Biological Sciences | Option exercise | 7,621 | $51.90K | Form 4 |
| Aug 18, 2025 | Klein UweSVP, Biological Sciences | Option exercise | 4,935 | $13.62K | Form 4 |
| Aug 18, 2025 | Klein UweSVP, Biological Sciences | Option exercise | 10,452 | $28.85K | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4